These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3945972

  • 21. The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.
    Daley-Yates PT, McBrien DC.
    Biochem Pharmacol; 1985 May 01; 34(9):1423-8. PubMed ID: 4039567
    [Abstract] [Full Text] [Related]

  • 22. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
    Osman NM, Copley MP, Litterst CL.
    Cancer Chemother Pharmacol; 1984 May 01; 13(1):58-62. PubMed ID: 6428763
    [Abstract] [Full Text] [Related]

  • 23. In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS.
    Hermann G, Heffeter P, Falta T, Berger W, Hann S, Koellensperger G.
    Metallomics; 2013 Jun 01; 5(6):636-47. PubMed ID: 23487031
    [Abstract] [Full Text] [Related]

  • 24. Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?
    Viale M, Vannozzi MO, Pastrone I, Mariggiò MA, Zicca A, Cadoni A, Cafaggi S, Tolino G, Lunardi G, Civalleri D, Lindup WE, Esposito M.
    J Pharmacol Exp Ther; 2000 Jun 01; 293(3):829-36. PubMed ID: 10869382
    [Abstract] [Full Text] [Related]

  • 25. Platinum accumulation in the kidney and changes in creatinine clearance following chemotherapy with cisplatin in humans.
    Uozumi J, Ueda T, Yasumasu T, Koikawa Y, Naito S, Kumazawa J, Kamura T, Nakano H, Sueishi K.
    Urol Int; 1993 Jun 01; 51(2):57-61. PubMed ID: 8351755
    [Abstract] [Full Text] [Related]

  • 26. Renal accumulation and urinary excretion of cisplatin in diabetic rats.
    Valentovic MA, Scott LA, Madan E, Yokel RA.
    Toxicology; 1991 Jun 01; 70(2):151-62. PubMed ID: 1763412
    [Abstract] [Full Text] [Related]

  • 27. Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin.
    Parti R, Wolf W.
    Cancer Chemother Pharmacol; 1990 Jun 01; 26(3):188-92. PubMed ID: 2357765
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin.
    Safirstein R, Daye M, Guttenplan JB.
    Cancer Lett; 1983 Apr 01; 18(3):329-38. PubMed ID: 6682696
    [Abstract] [Full Text] [Related]

  • 31. Reduction of cisplatin-induced nephrotoxicity in vivo by selenomethionine: the effect on cisplatin-DNA adducts.
    García Sar D, Montes-Bayón M, Blanco González E, Sierra Zapico LM, Sanz-Medel A.
    Chem Res Toxicol; 2011 Jun 20; 24(6):896-904. PubMed ID: 21491944
    [Abstract] [Full Text] [Related]

  • 32. Uptake and metabolism of cisplatin by rat kidney.
    Safirstein R, Miller P, Guttenplan JB.
    Kidney Int; 1984 May 20; 25(5):753-8. PubMed ID: 6540826
    [Abstract] [Full Text] [Related]

  • 33. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.
    Litterst CL, Gram TE, Dedrick RL, Leroy AF, Guarino AM.
    Cancer Res; 1976 Jul 20; 36(7 PT 1):2340-4. PubMed ID: 1277140
    [Abstract] [Full Text] [Related]

  • 34. A study of the protective effect of chloride salts on cisplatin nephrotoxicity.
    Daley-Yates PT, McBrien DC.
    Biochem Pharmacol; 1985 Jul 01; 34(13):2363-9. PubMed ID: 4040367
    [Abstract] [Full Text] [Related]

  • 35. The effects of dimercaptosuccinic acid and other chelating agents on the retention of platinum in the rat kidney after treatment with cisplatin.
    Planas-Bohne F, Shand E, Taylor DM.
    Cancer Chemother Pharmacol; 1982 Jul 01; 9(2):120-1. PubMed ID: 6293731
    [Abstract] [Full Text] [Related]

  • 36. Changes in renal handling of platinum in cisplatinum-treated rats following induction of metabolic acidosis or alkalosis.
    Bertolero F, Litterst CL.
    Res Commun Chem Pathol Pharmacol; 1982 May 01; 36(2):273-85. PubMed ID: 7201666
    [Abstract] [Full Text] [Related]

  • 37. The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.
    Graziano J, Jones B, Pisciotto P.
    Br J Pharmacol; 1981 Jul 01; 73(3):649-54. PubMed ID: 6265016
    [Abstract] [Full Text] [Related]

  • 38. The effect of methylprednisolone on platinum kinetics and urinary enzyme excretion following intravenous cisplatin in vivo and on the growth inhibition of LLC-PK1 cells by cisplatin in vitro.
    Uozumi J, Koikawa Y, Yasumasu T, Tokuda N, Ueda T, Kumazawa J.
    Res Exp Med (Berl); 1996 Jul 01; 196(4):211-7. PubMed ID: 8903096
    [Abstract] [Full Text] [Related]

  • 39. Renal metallothionein and platinum levels in diabetic and nondiabetic rats injected with cisplatin.
    Cacini W, Singh Y.
    Proc Soc Exp Biol Med; 1991 Jul 01; 197(3):285-9. PubMed ID: 2068122
    [Abstract] [Full Text] [Related]

  • 40. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
    Martinčič A, Cemazar M, Sersa G, Kovač V, Milačič R, Ščančar J.
    Talanta; 2013 Nov 15; 116():141-8. PubMed ID: 24148385
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.